Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1964 May;43(5):931–942. doi: 10.1172/JCI104979

The Effects of Noncalorigenic Congeners of Salicylate on the Peripheral Metabolism of Thyroxine*

Kenneth A Woeber 1, Sidney H Ingbar 1
PMCID: PMC289572  PMID: 14169522

Full text

PDF
931

Images in this article

935Image
on p.935

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDREWS M. M. The relative potencies of some substituted salicylic acids as metabolic stimulants in the intact rat. Br J Pharmacol Chemother. 1958 Dec;13(4):419–423. doi: 10.1111/j.1476-5381.1958.tb00232.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. AUSTEN F. K., RUBINI M. E., MERONEY W. H., WOLFF J. Salicylates and thyroid function. I. Depression of thyroid function. J Clin Invest. 1958 Aug;37(8):1131–1143. doi: 10.1172/JCI103703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BENOTTI J., BENOTTI N. PROTEIN-BOUND IODINE, TOTAL IODINE, AND BUTANOL-EXTRACTABLE IODINE BY PARTIAL AUTOMATION. Clin Chem. 1963 Aug;12:408–416. [PubMed] [Google Scholar]
  4. BRODY T. M. Action of sodium salicylate and related compounds on tissue metabolism in vitro. J Pharmacol Exp Ther. 1956 May;117(1):39–51. [PubMed] [Google Scholar]
  5. CASTOR C. W., BEIERWALTES W. Effect of 2, 4-dinitrophenol on thyroid function in man. J Clin Endocrinol Metab. 1956 Aug;16(8):1026–1031. doi: 10.1210/jcem-16-8-1026. [DOI] [PubMed] [Google Scholar]
  6. CLARKE N. E., CLARKE C. N., MOSHER R. E. Phenolic compounds in chemotherapy of rheumatic fever. Am J Med Sci. 1958 Jan;235(1):7–22. doi: 10.1097/00000441-195801000-00002. [DOI] [PubMed] [Google Scholar]
  7. CLARKE N. E., MOSHER R. E., CLARKE C. N. Phenolic compounds in the treatment of rheumatic fever. I. A study of gentisic acid derivatives. Circulation. 1953 Feb;7(2):247–257. doi: 10.1161/01.cir.7.2.247. [DOI] [PubMed] [Google Scholar]
  8. DOWLING J. T., FREINKEL N., INGBAR S. H. The effect of estrogens upon the peripheral metabolism of thyroxine. J Clin Invest. 1960 Jul;39:1119–1130. doi: 10.1172/JCI104127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. FEDERMAN D. D., ROBBINS J., RALL J. E. Effects of methyl testosterone on thyroid function, thyrozine metabolism, and thyroxine-binding protein. J Clin Invest. 1958 Jul;37(7):1024–1030. doi: 10.1172/JCI103683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. GERALD P. S., KAGAN B. M. A method for the determination of gentisic acid in serum. J Biol Chem. 1951 Apr;189(2):467–472. [PubMed] [Google Scholar]
  11. GORDON A. H., GROSS J., O'CONNOR D., PITT-RIVERS R. Nature of the circulating thyroid hormone-plasma protein complex. Nature. 1952 Jan 5;169(4288):19–20. doi: 10.1038/169019a0. [DOI] [PubMed] [Google Scholar]
  12. HOLLANDER C. S., ODAK V. V., PROUT T. E., ASPER S. P., Jr An evaluation of the role of prealbumin in the binding of thyroxine. J Clin Endocrinol Metab. 1962 Jun;22:617–622. doi: 10.1210/jcem-22-6-617. [DOI] [PubMed] [Google Scholar]
  13. INGBAR S. H., FREINKEL N. Regulation of the peripheral metabolism of the thyroid hormones. Recent Prog Horm Res. 1960;16:353–403. [PubMed] [Google Scholar]
  14. INGBAR S. H., FREINKEL N. Simultaneous estimation of rates of thyroxine degradation and thyroid hormone synthesis. J Clin Invest. 1955 Jun;34(6):808–819. doi: 10.1172/JCI103136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. INGBAR S. H., FREINKEL N. Studies of thyroid function and the peripheral metabolism of I 131-labeled thyroxine in patients with treated Graves disease. J Clin Invest. 1958 Nov;37(11):1603–1614. doi: 10.1172/JCI103753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. INGBAR S. H. Observations concerning the binding of thyroid hormones by human serum prealbumin. J Clin Invest. 1963 Feb;42:143–160. doi: 10.1172/JCI104701. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. INGBAR S. H. Pre-albumin: a thyroxinebinding protein of human plasma. Endocrinology. 1958 Aug;63(2):256–259. doi: 10.1210/endo-63-2-256. [DOI] [PubMed] [Google Scholar]
  18. Ingbar S. H. CLINICAL AND PHYSIOLOGICAL OBSERVATIONS IN A PATIENT WITH AN IDIOPATHIC DECREASE IN THE THYROXINE-BINDING GLOBULIN OF PLASMA. J Clin Invest. 1961 Nov;40(11):2053–2063. doi: 10.1172/JCI104431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. MEADE B. W. Effect of certain hydroxybenzoic acids on the oxygen consumption of Wistar rats. Ann Rheum Dis. 1954 Mar;13(1):60–62. doi: 10.1136/ard.13.1.60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. MYANT N. B. Relation between the biliary clearance rate of thyroxine and the binding of thyroxine by the serum proteins. J Physiol. 1957 Feb 15;135(2):426–441. doi: 10.1113/jphysiol.1957.sp005721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Meyer K., Ragan C. The Antirheumatic Effect of Sodium Gentisate. Science. 1948 Sep 10;108(2802):281–281. doi: 10.1126/science.108.2802.281. [DOI] [PubMed] [Google Scholar]
  22. OPPENHEIMER J. H., SQUEF R., SURKS M. I., HAUER H. BINDING OF THYROXINE BY SERUM PROTEINS EVALUATED BY EQUILIBRUM DIALYSIS AND ELECTROPHORETIC TECHNIQUES. ALTERATIONS IN NONTHYROIDAL ILLNESS. J Clin Invest. 1963 Nov;42:1769–1782. doi: 10.1172/JCI104862. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. RICHARDS J. B., INGBAR S. H. The effects of propylthiouracil and perchlorate on the biogenesis of thyroid hormone. Endocrinology. 1959 Aug;65(2):198–207. doi: 10.1210/endo-65-2-198. [DOI] [PubMed] [Google Scholar]
  24. ROBBINS J., RALL J. E. Proteins associated with the thyroid hormones. Physiol Rev. 1960 Jul;40:415–489. doi: 10.1152/physrev.1960.40.3.415. [DOI] [PubMed] [Google Scholar]
  25. Riggs D. S., Man E. B., Winkler A. W. SERUM IODINE OF EUTHYROID SUBJECTS TREATED WITH DESICCATED THYROID. J Clin Invest. 1945 Sep;24(5):722–731. doi: 10.1172/JCI101657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. SCHAEFER L. E., RASHKOFF I. A., MEGIBOW R. S. Sodium gentisate in the treatment of acute rheumatic fever. Circulation. 1950 Aug;2(2):265–270. doi: 10.1161/01.cir.2.2.265. [DOI] [PubMed] [Google Scholar]
  27. STERLING K., CHODOS R. B. Radiothyroxine turnover studies in myxedema, thyrotoxicosis, and hypermetabolism without endocrine disease. J Clin Invest. 1956 Jul;35(7):806–813. doi: 10.1172/JCI103333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. TAUROG A. Deiodination of [131-I] thyroxine on filter paper. Biochim Biophys Acta. 1962 Jun 18;60:197–199. doi: 10.1016/0006-3002(62)90393-1. [DOI] [PubMed] [Google Scholar]
  29. WOEBER K. A., INGBAR S. H. Effect of salicylate on the binding of thyroxine by human serum proteins at pH 7.4. Endocrinology. 1963 Jul;73:118–119. doi: 10.1210/endo-73-1-118. [DOI] [PubMed] [Google Scholar]
  30. WOLFF J., AUSTEN F. K. Salicylates and thyroid function. II. The effect on the thyroid-pituitary interrelation. J Clin Invest. 1958 Aug;37(8):1144–1152. doi: 10.1172/JCI103704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. WOLFF J., STANDAERT M. E., RALL J. E. Thyroxine displacement from serum proteins and depression of serum protein-bound iodine by certain drugs. J Clin Invest. 1961 Aug;40:1373–1379. doi: 10.1172/JCI104368. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES